Search This Blog

Monday, June 3, 2019

TransMedics (TMDX) Reports Second FDA PMA Approval for OCS Lung System

TransMedics Group, Inc. (NASDAQ: TMDX) today announced that it has received an FDA PMA approval for expanded clinical indications.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.